Daiken Medical Co., Ltd.
Tokyo Stock Exchange 7775.T
Daiken Medical Co., Ltd. Revenue for the year ending March 31, 2024: USD 64.42 M
Daiken Medical Co., Ltd. Revenue is USD 64.42 M for the year ending March 31, 2024, a -6.33% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Daiken Medical Co., Ltd. Revenue for the year ending March 31, 2023 was USD 68.77 M, a -1.97% change year over year.
-
Daiken Medical Co., Ltd. Revenue for the year ending March 31, 2022 was USD 70.16 M, a -1.17% change year over year.
-
Daiken Medical Co., Ltd. Revenue for the year ending March 31, 2021 was USD 70.99 M, a -10.43% change year over year.
-
Daiken Medical Co., Ltd. Revenue for the year ending March 31, 2020 was USD 79.26 M, a 4.54% change year over year.
Key data
| Date | Revenue | Gross Profit | Operating Income | EBIT |
|---|
Market news
Loading...
Tokyo Stock Exchange: 7775.T
| CEO | Mr. Keiichi Yamada |
| IPO Date | March 12, 2009 |
| Location | Japan |
| Headquarters | 2-6-2, Ayumino |
| Employees | 175 |
| Sector | Health Care |
| Industries | |
Description
Daiken Medical Co., Ltd. manufactures and distributes medical devices and equipment in Japan and internationally. The company offers syringe pumps, disposable infusion pumps, portable disposable infusers, endobronchial blocker tubes, suction containers, connecting tubes, suction tips, medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. It also trades in medical equipment. The company sells its products under the COOPDECH brand. Daiken Medical Co., Ltd. was incorporated in 1968 and is headquartered in Izumi, Japan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email